Brand Name Drug Company Beats Earnings Forecasts After Repeatedly Hiking Prices

New earnings reports for the second quarter of 2020 show that Big Pharma giants are continuing to rake in profits while hiking prescription drug prices.

On Tuesday, Big Pharma drug company Novartis announced it bested earnings forecasts for the second quarter after hiking prices on nearly 30 drugs earlier this year.

Novartis’ earnings come as the company continues to hike prices on their prescription drugs despite a growing crisis of affordability.

Stay tuned this week as we continue to monitor Q2 earnings announcements from brand name drug companies.




Sign-up for updates

  • This field is for validation purposes and should be left unchanged.